At RSI, Dr. Natalia (Natasha) Shilnikova has been working on projects involving toxicology, epidemiology and human health risk assessment, such as development of toxicity profiles for several chemicals on Health Canada’s Domestic Substances List (DSL); a...

Dr. Momoli is the Practice Lead for Chemical and Product Safety at Risk Sciences International, as well as an adjunct professor in the School of Epidemiology and Public Health at the University of Ottawa.

Douglas McNair is one of four Cerner software developers who have received the designation Engineering Fellow. He previously served as President of Cerner Math.

Prior to joining Kuwait University, Dr. Al-Zoughool was an associate professor and director of the Quality Assurance & Academic Accreditation Unit, at the College of Public Health, King Saud Bin Abdulaziz University for Health Sciences in Saudi Arabia. From 2006-2012, Dr. Al-Zoughool worked in Canada at the McLaughlin Center for Population Health Risk Assessment, University of Ottawa. Before that, he completed a one-year postdoctoral fellowship at the International Agency for Research on Cancer (IARC) in Lyon, France from 2005- 2006.

Martin LeBlanc is responsible for growing RSI’s book of business, supporting all activities to this end. His line is always open to assist clients old and new. He strives to understand and provide a client’s unique need on a project, having done so for many government and...

As Office Administrator for RSI, Monique is responsible for managing all functions of the firm’s office environment and administration needs, including liaising with stakeholders, contractors and suppliers, supporting RSI Directors and staff with data management and word...

Dr. Donald Mattison was appointed Chief Medical Officer and Senior Vice President of Risk Sciences International in 2012. Dr. Mattison also serves as Associate Director of the McLaughlin Centre for Population Health Risk Assessment and as Adjunct Professor at...

Shintaro started working with Risk Sciences International as a student in 2018, and officially joined full-time in 2023. Shintaro focuses on the application of the VOI framework and developing health-based guideline values via dose-response analysis for...

Dr. Hartnett currently works on the development of risk-based decision-making processes and tools to support public risk assessment. Current focus includes: working with the Canadian Food Inspection Agency exploring methodologies to support risk-based...

Dr. Bird is an Associate Expert at Risk Sciences International and an Affiliate Scientist at McLaughlin Centre for Human Health Risk Assessment, and has an adjunct appointment at the Ernest Mario School of Pharmacy, Rutgers University, NJ, USA.